当前位置:首页 - 行情中心 - 九安医疗(002432) - 财务分析

九安医疗

(002432)

  

流通市值:176.70亿  总市值:187.41亿
流通股本:4.38亿   总股本:4.65亿

九安医疗(002432)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润15.88亿元,每股收益3.66元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益2242101.55万元,未分配利润1965496.98万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2898162.08万元,负债656060.53万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,069,311,569.11765,265,184.21506,998,641.122,592,196,225.39
营业总成本1,275,596,464.12897,862,987.49442,333,724.731,884,214,150.2
其他经营收益
营业利润1,595,068,871.16981,091,127.85303,555,606.022,109,802,117.61
利润总额1,596,307,146.21981,043,992.75303,501,468.212,106,869,818.06
净利润1,587,758,433.66920,175,295.83277,815,657.51,800,042,144.8
每股收益
其他综合收益81,832,104.69361,186,484.93240,079,618.96696,472,446.46
综合收益总额1,669,590,538.351,281,361,780.76517,895,276.462,496,514,591.26
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计15,222,829,419.915,535,869,391.1814,276,093,278.6814,077,286,222.89
非流动资产:
非流动资产合计13,758,791,392.4113,123,556,839.8312,389,433,264.5312,258,066,152.87
资产总计28,981,620,812.3128,659,426,231.0126,665,526,543.2126,335,352,375.76
流动负债:
流动负债合计3,189,095,554.214,525,978,981.193,236,458,817.082,560,084,645.18
非流动负债:
非流动负债合计3,371,509,709.022,093,639,356.251,738,453,873.62,284,650,512.99
负债合计6,560,605,263.236,619,618,337.444,974,912,690.684,844,735,158.17
所有者权益(或股东权益):
归属于母公司股东权益合计22,189,231,323.921,774,412,884.0721,421,900,400.8820,736,503,543.76
股东权益合计22,421,015,549.0822,039,807,893.5721,690,613,852.5321,490,617,217.59
负债和股东权益合计28,981,620,812.3128,659,426,231.0126,665,526,543.2126,335,352,375.76
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,222,138,963.14888,299,929.66425,532,491.222,797,527,196.32
经营活动现金流出小计1,256,207,811.73872,041,227.11418,217,387.371,810,774,325.27
经营活动产生的现金流量净额-34,068,848.5916,258,702.557,315,103.85986,752,871.05
投资活动产生的现金流量:
投资活动现金流入小计9,275,809,471.953,645,342,159.432,706,047,730.7915,298,693,624.51
投资活动现金流出小计9,939,251,224.424,810,337,593.463,137,021,922.0115,879,964,288.71
投资活动产生的现金流量净额-663,441,752.47-1,164,995,434.03-430,974,191.22-581,270,664.2
筹资活动产生的现金流量:
筹资活动现金流入小计7,106,440,878.063,811,604,717.441,072,866,127.63,998,037,048.79
筹资活动现金流出小计6,227,292,227.493,229,740,383.681,149,266,891.973,901,831,315.42
筹资活动产生的现金流量净额879,148,650.57581,864,333.76-76,400,764.3796,205,733.37
汇率变动对现金及现金等价物的影响-36,864,029.35-11,002,856.19-5,620,578.1943,938,792.7
现金及现金等价物净增加额144,774,020.16-577,875,253.91-505,680,429.93545,626,732.92
期末现金及现金等价物余额2,980,402,870.682,257,753,596.612,329,948,420.592,835,628,850.52
补充资料:
现金及现金等价物的净增加额--577,875,253.91-545,626,732.92
最新报告期:2025-11-21
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华创证券郑辰,李婵娟5.045.556.152025-11-21
华创证券郑辰,李婵娟3.844.234.692025-09-15
TOP↑